Clinical Trial Update: Pyruvate Kinase Deficiency Global Longitudinal Registry

View source ↗

Summary

A global longitudinal registry for Pyruvate Kinase Deficiency sponsored by Agios Pharmaceuticals, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyruvate Kinase Deficiency

Snippet

Sponsor: Agios Pharmaceuticals, Inc. | Conditions: Pyruvate Kinase Deficiency | Status: ACTIVE_NOT_RECRUITING